DGX

SEC source: 0001022079-17-000176 · wf-form4_150481699835822.xml · derivative · entry 11

STANZIONE DANIEL · CIK 0001221534 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,221

Underlying: Common Stock · 1,004 shares

Expires 2023-05-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on August 3, 2017.

F7 · derivative.exercise_date: The options vested in three annual installments beginning with the first on May 21, 2014, the second on May 21, 2015 and the final on May 21, 2016.

SEC source: 0001022079-17-000176 · wf-form4_150481699835822.xml · derivative · entry 10

STANZIONE DANIEL · CIK 0001221534 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,268

Underlying: Common Stock · 915 shares

Expires 2022-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on August 3, 2017.

F6 · derivative.exercise_date: The options vested in three annual installments beginning with the first on May 11, 2013, the second on May 11, 2014 and the final on May 11, 2015.

SEC source: 0001022079-17-000176 · wf-form4_150481699835822.xml · derivative · entry 9

STANZIONE DANIEL · CIK 0001221534 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,592

Underlying: Common Stock · 519 shares

Expires 2021-05-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on August 3, 2017.

F5 · derivative.exercise_date: The options vested in three annual installments beginning with the first on May 17, 2012, the second on May 17, 2013 and the final on May 17, 2014.

SEC source: 0001022079-17-000176 · wf-form4_150481699835822.xml · derivative · entry 8

STANZIONE DANIEL · CIK 0001221534 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,319

Underlying: Common Stock · 681 shares

Expires 2020-05-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on August 3, 2017.

F4 · derivative.exercise_date: The options vested in three annual installments beginning with the first on May 6, 2011, the second on May 6, 2012 and the final on May 6, 2013.

SEC source: 0001022079-17-000176 · wf-form4_150481699835822.xml · derivative · entry 7

STANZIONE DANIEL · CIK 0001221534 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,316

Underlying: Common Stock · 684 shares

Expires 2019-05-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on August 3, 2017.

F3 · derivative.exercise_date: The options vested in three annual installments beginning with the first on May 14, 2010, the second on May 14, 2011 and the final on May 14, 2012.

SEC source: 0001022079-17-000176 · wf-form4_150481699835822.xml · nonDerivative · entry 6

STANZIONE DANIEL · CIK 0001221534 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,675

F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on August 3, 2017.

F2 · price: This transaction was executed in multiple trades at prices ranging from $108.00 to $108.02. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001022079-17-000176 · wf-form4_150481699835822.xml · nonDerivative · entry 5

STANZIONE DANIEL · CIK 0001221534 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,478

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on August 3, 2017.

SEC source: 0001022079-17-000176 · wf-form4_150481699835822.xml · nonDerivative · entry 4

STANZIONE DANIEL · CIK 0001221534 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,474

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on August 3, 2017.

SEC source: 0001022079-17-000176 · wf-form4_150481699835822.xml · nonDerivative · entry 3

STANZIONE DANIEL · CIK 0001221534 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,559

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on August 3, 2017.

SEC source: 0001022079-17-000176 · wf-form4_150481699835822.xml · nonDerivative · entry 2

STANZIONE DANIEL · CIK 0001221534 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,040

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on August 3, 2017.

SEC source: 0001022079-17-000176 · wf-form4_150481699835822.xml · nonDerivative · entry 1

STANZIONE DANIEL · CIK 0001221534 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,359

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on August 3, 2017.

SEC source: 0001022079-17-000174 · wf-form4_150481683383336.xml · derivative · entry 3

RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 166,075

Underlying: Common Stock · 2,525 shares

Expires 2022-05-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on August 3, 2017.

F4 · derivative.exercise_date: The options vested in three annual installments beginning with the first on May 1, 2013, the second on May 1, 2014 and the final on May 1, 2015.

SEC source: 0001022079-17-000174 · wf-form4_150481683383336.xml · nonDerivative · entry 2

RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 166,116

F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on August 3, 2017.

F2 · price: This transaction was executed in multiple trades at prices ranging from $108.00 to $108.10. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4.

SEC source: 0001022079-17-000174 · wf-form4_150481683383336.xml · nonDerivative · entry 1

RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 168,413

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on August 3, 2017.

SEC source: 0001022079-17-000166 · wf-form4_150222401171554.xml · nonDerivative · entry 1

LEIDEN JEFFREY M · CIK 0001242825 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,000

F1 · price: This transaction was executed in multiple trades at prices ranging from $106.657 to $106.66. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001022079-17-000163 · wf-form4_150179222829209.xml · nonDerivative · entry 1

Cohen Jon R · CIK 0001477972 · SVP & Group Exec. Diag. Sol.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,683

SEC source: 0001022079-17-000161 · wf-form4_150153371086914.xml · nonDerivative · entry 1

LEIDEN JEFFREY M · CIK 0001242825 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,296

F1 · price: This transaction was executed in multiple trades at prices ranging from $108.729 to $108.73. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001022079-17-000153 · wf-form4_149928691121173.xml · derivative · entry 1

RING TIMOTHY M · CIK 0001204666 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,516.281

Underlying: Common Stock · 276 shares

Expires not disclosed

F1 · derivative.exercise_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director.

F1 · derivative.expiration_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director.

F2 · balance_after: Total number of phantom stock units accrued as of the transaction date in the reporting person's deferred compensation account includes phantom stock units credited as a result of dividend reinvestment transactions exempt from reporting pursuant to Rule 16a-11.

SEC source: 0001022079-17-000151 · wf-form4_149807686777487.xml · derivative · entry 12

Cohen Jon R · CIK 0001477972 · SVP & Group Exec. Diag. Sol.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 63,880 shares

Expires 2024-02-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 16, 2017.

F8 · derivative.exercise_date: The options vested in three annual installments beginning with the first on February 13, 2014, the second on February 13, 2015 and the final on February 13, 2016.

SEC source: 0001022079-17-000151 · wf-form4_149807686777487.xml · derivative · entry 11

Cohen Jon R · CIK 0001477972 · SVP & Group Exec. Diag. Sol.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 29,340 shares

Expires 2023-02-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 16, 2017.

F7 · derivative.exercise_date: The options vested in three annual installments beginning with the first on February 25, 2013 the second on February 25, 2014 and the final on February 25, 2015.

SEC source: 0001022079-17-000151 · wf-form4_149807686777487.xml · derivative · entry 10

Cohen Jon R · CIK 0001477972 · SVP & Group Exec. Diag. Sol.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 13,680 shares

Expires 2022-02-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 16, 2017.

F6 · derivative.exercise_date: The options vested in three annual installments beginning with the first on February 27, 2012, the second February 27, 2013 and the final on February 27, 2014.

SEC source: 0001022079-17-000151 · wf-form4_149807686777487.xml · nonDerivative · entry 9

Cohen Jon R · CIK 0001477972 · SVP & Group Exec. Diag. Sol.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 73,183

F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 16, 2017.

F5 · price: This transaction was executed in multiple trades at prices ranging from $108.12 to $108.15. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001022079-17-000151 · wf-form4_149807686777487.xml · nonDerivative · entry 8

Cohen Jon R · CIK 0001477972 · SVP & Group Exec. Diag. Sol.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,742

F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 16, 2017.

F2 · price: This transaction was executed in multiple trades at prices ranging from $107.12 to $108.12. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001022079-17-000151 · wf-form4_149807686777487.xml · nonDerivative · entry 7

Cohen Jon R · CIK 0001477972 · SVP & Group Exec. Diag. Sol.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 137,063

F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 16, 2017.

F4 · price: This transaction was executed in multiple trades at prices ranging from $108.12 to $108.17. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001022079-17-000151 · wf-form4_149807686777487.xml · nonDerivative · entry 6

Cohen Jon R · CIK 0001477972 · SVP & Group Exec. Diag. Sol.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 138,221

F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 16, 2017.

F2 · price: This transaction was executed in multiple trades at prices ranging from $107.12 to $108.12. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001022079-17-000151 · wf-form4_149807686777487.xml · nonDerivative · entry 5

Cohen Jon R · CIK 0001477972 · SVP & Group Exec. Diag. Sol.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 166,403

F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 16, 2017.

F3 · price: This transaction was executed in multiple trades at prices ranging from $108.14 to $108.15. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001022079-17-000151 · wf-form4_149807686777487.xml · nonDerivative · entry 4

Cohen Jon R · CIK 0001477972 · SVP & Group Exec. Diag. Sol.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 166,739

F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 16, 2017.

F2 · price: This transaction was executed in multiple trades at prices ranging from $107.12 to $108.12. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001022079-17-000151 · wf-form4_149807686777487.xml · nonDerivative · entry 3

Cohen Jon R · CIK 0001477972 · SVP & Group Exec. Diag. Sol.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 180,083

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 16, 2017.

SEC source: 0001022079-17-000151 · wf-form4_149807686777487.xml · nonDerivative · entry 2

Cohen Jon R · CIK 0001477972 · SVP & Group Exec. Diag. Sol.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 116,203

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 16, 2017.

SEC source: 0001022079-17-000151 · wf-form4_149807686777487.xml · nonDerivative · entry 1

Cohen Jon R · CIK 0001477972 · SVP & Group Exec. Diag. Sol.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 86,863

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 16, 2017.

SEC source: 0001022079-17-000150 · wf-form4_149807682728949.xml · derivative · entry 13

Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,595 shares

Expires 2023-02-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 18, 2017.

F9 · derivative.exercise_date: The options vested in three annual installments beginning with the first on February 25, 2014, the second on February 25, 2015 and the final on February 25, 2016.

SEC source: 0001022079-17-000150 · wf-form4_149807682728949.xml · derivative · entry 12

Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 44,000 shares

Expires 2022-02-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 18, 2017.

F8 · derivative.exercise_date: The options vested in three annual installments beginning with the first on February 27, 2013, the second on February 27, 2014 and the final on February 27, 2015.

SEC source: 0001022079-17-000150 · wf-form4_149807682728949.xml · derivative · entry 11

Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 9,167 shares

Expires 2021-05-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 18, 2017.

F7 · derivative.exercise_date: The options vested in three annual installments beginning with the first on May 16, 2012, the second on May 16, 2013 and the final on May 16, 2014.

SEC source: 0001022079-17-000150 · wf-form4_149807682728949.xml · nonDerivative · entry 9

Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,415

F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 18, 2017.

SEC source: 0001022079-17-000150 · wf-form4_149807682728949.xml · nonDerivative · entry 8

Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,592

F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 18, 2017.

F4 · price: This transaction was executed in multiple trades at prices ranging from $107.12 to $108.11. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001022079-17-000150 · wf-form4_149807682728949.xml · nonDerivative · entry 7

Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,010

F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 18, 2017.

F5 · price: This transaction was executed in multiple trades at prices ranging from $108.12 to $108.16. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001022079-17-000150 · wf-form4_149807682728949.xml · nonDerivative · entry 6

Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,374

F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 18, 2017.

F4 · price: This transaction was executed in multiple trades at prices ranging from $107.12 to $108.11. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001022079-17-000150 · wf-form4_149807682728949.xml · nonDerivative · entry 5

Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 120,010

F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 18, 2017.

F3 · price: This transaction was executed in multiple trades at prices ranging from $108.15 to $108.16. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001022079-17-000150 · wf-form4_149807682728949.xml · nonDerivative · entry 4

Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 120,325

F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 18, 2017.

F2 · price: This transaction was executed in multiple trades at prices ranging from $107.14 to $108.12. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001022079-17-000150 · wf-form4_149807682728949.xml · nonDerivative · entry 3

Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 129,177

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 18, 2017.

SEC source: 0001022079-17-000150 · wf-form4_149807682728949.xml · nonDerivative · entry 2

Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 122,582

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 18, 2017.

SEC source: 0001022079-17-000150 · wf-form4_149807682728949.xml · nonDerivative · entry 1

Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 78,582

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 18, 2017.

SEC source: 0001022079-17-000143 · wf-form4_149557209354018.xml · nonDerivative · entry 1

Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,415

SEC source: 0001022079-17-000132 · wf-form4_149514001975414.xml · nonDerivative · entry 1

WILENSKY GAIL R · CIK 0001018538 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,960

F1 · security: Represents an award of restricted share units granted on May 16, 2017.

SEC source: 0001022079-17-000139 · wf-form4_149514036682342.xml · nonDerivative · entry 1

STANZIONE DANIEL · CIK 0001221534 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,675

F1 · security: Represents an award of restricted share units granted on May 16, 2017.

SEC source: 0001022079-17-000138 · wf-form4_149514032111908.xml · nonDerivative · entry 1

RING TIMOTHY M · CIK 0001204666 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,585

F1 · security: Represents an award of restricted share units granted on May 16, 2017.

F2 · balance_after: The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors.

SEC source: 0001022079-17-000137 · wf-form4_149514027887403.xml · nonDerivative · entry 1

PFEIFFER GARY M · CIK 0001127304 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,534

F1 · security: Represents an award of restricted share units granted on May 16, 2017.

F2 · balance_after: The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors.

SEC source: 0001022079-17-000136 · wf-form4_149514022765893.xml · nonDerivative · entry 1

MAIN TIMOTHY L · CIK 0001196744 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,691

F1 · security: Represents an award of restricted share units granted on May 16, 2017.

SEC source: 0001022079-17-000134 · wf-form4_149514012947244.xml · nonDerivative · entry 1

Gregg Vicky B · CIK 0001510304 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,525

F1 · security: Represents an award of restricted share units granted on May 16, 2017.

F2 · balance_after: The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors.

SEC source: 0001022079-17-000135 · wf-form4_149514017523365.xml · nonDerivative · entry 1

LEIDEN JEFFREY M · CIK 0001242825 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,600